JP2014521661A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014521661A5 JP2014521661A5 JP2014523099A JP2014523099A JP2014521661A5 JP 2014521661 A5 JP2014521661 A5 JP 2014521661A5 JP 2014523099 A JP2014523099 A JP 2014523099A JP 2014523099 A JP2014523099 A JP 2014523099A JP 2014521661 A5 JP2014521661 A5 JP 2014521661A5
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- molecule
- amino acid
- use according
- kda
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161513287P | 2011-07-29 | 2011-07-29 | |
| US61/513,287 | 2011-07-29 | ||
| PCT/US2012/048732 WO2013019681A2 (en) | 2011-07-29 | 2012-07-27 | Selective delivery molecules and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014521661A JP2014521661A (ja) | 2014-08-28 |
| JP2014521661A5 true JP2014521661A5 (enExample) | 2015-08-13 |
| JP6124150B2 JP6124150B2 (ja) | 2017-05-10 |
Family
ID=47629864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014523099A Expired - Fee Related JP6124150B2 (ja) | 2011-07-29 | 2012-07-27 | 選択的な送達分子及び使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (6) | US9278144B2 (enExample) |
| EP (2) | EP3473273A1 (enExample) |
| JP (1) | JP6124150B2 (enExample) |
| KR (1) | KR102004558B1 (enExample) |
| CN (1) | CN103874512B (enExample) |
| AU (1) | AU2012290318B2 (enExample) |
| CA (1) | CA2841249C (enExample) |
| DK (1) | DK2736533T3 (enExample) |
| EA (1) | EA030795B1 (enExample) |
| ES (1) | ES2683377T3 (enExample) |
| MX (1) | MX350082B (enExample) |
| WO (1) | WO2013019681A2 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9695251B2 (en) | 2003-10-31 | 2017-07-04 | The Regents Of The University Of California | Activatable cell penetrating peptides with quenched fluorophores |
| US7985401B2 (en) | 2003-10-31 | 2011-07-26 | The Regents Of The University Of California | Peptides whose uptake by cells is controllable |
| WO2011008992A2 (en) | 2009-07-15 | 2011-01-20 | The Regents Of The University Of California | Peptides whose uptake in cells is controllable |
| US8673267B2 (en) | 2009-03-02 | 2014-03-18 | Massachusetts Institute Of Technology | Methods and products for in vivo enzyme profiling |
| AU2012290318B2 (en) | 2011-07-29 | 2016-09-01 | Avelas Biosciences, Inc. | Selective delivery molecules and methods of use |
| US10029017B2 (en) | 2013-01-29 | 2018-07-24 | The Regents Of The University Of California | Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug |
| KR102363779B1 (ko) | 2013-01-30 | 2022-02-15 | 아벨라스 바이오사이언시즈 인코포레이티드 | 선택적 전달 분자 및 사용 방법 |
| EP2988786A4 (en) * | 2013-04-22 | 2016-12-21 | Avelas Biosciences Inc | COMPOSITIONS FOR SELECTIVE DRUG ADMINISTRATION AND METHOD OF USE |
| PL405046A1 (pl) * | 2013-08-12 | 2015-02-16 | Instytut Biologii Doświadczalnej Im. Marcelego Nenckiego Pan | Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie |
| US10385380B2 (en) | 2014-10-02 | 2019-08-20 | The Regents Of The University Of California | Personalized protease assay to measure protease activity in neoplasms |
| US10596259B2 (en) | 2015-05-20 | 2020-03-24 | The Regents Of The University Of California | Tumor radiosensitization with monomethyl auristatin E (MMAE) and derivatives thereof |
| WO2017211278A1 (en) * | 2016-06-06 | 2017-12-14 | Asclepiumm Taiwan Co., Ltd | Antibody fusion proteins for drug delivery |
| EA201992252A1 (ru) | 2017-04-07 | 2020-04-02 | Авелас Байосайенсиз, Инк. | Логометрические способы визуализации флуоресценции |
| CN110709174A (zh) | 2017-06-22 | 2020-01-17 | 宝洁公司 | 包括水溶性层和气相沉积有机涂层的膜 |
| US10450119B2 (en) * | 2017-06-22 | 2019-10-22 | The Procter & Gamble Company | Films including a water-soluble layer and a vapor-deposited inorganic coating |
| CN108096255B (zh) * | 2017-12-28 | 2019-11-12 | 北京大学 | 地夫可特用于抑制或治疗胰腺癌的用途 |
| US11054428B2 (en) | 2018-03-05 | 2021-07-06 | Massachusetts Institute Of Technology | Inhalable nanosensors with volatile reporters and uses thereof |
| US20220347306A1 (en) * | 2018-04-16 | 2022-11-03 | Avelas Biosciences, Inc. | Selective delivery of therapeutic and imaging agents |
| WO2020068920A2 (en) | 2018-09-25 | 2020-04-02 | Massachusetts Institute Of Technology | Lung protease nanosensors and uses thereof |
| EP3911753A1 (en) | 2019-01-17 | 2021-11-24 | Massachusetts Institute of Technology | Sensors for detecting and imaging of cancer metastasis |
| CN110075322B (zh) * | 2019-05-20 | 2021-07-06 | 复旦大学附属妇产科医院 | 一种靶向GnRH受体的近红外荧光成像探针及其制备方法与应用 |
| EP4034567A4 (en) * | 2019-09-23 | 2023-07-05 | Neonc Technologies, Inc. | PHARMACEUTICAL COMPOSITIONS WITH POH DERIVATIVES |
| EP4683668A1 (en) * | 2023-05-05 | 2026-01-28 | The United States Government as Represented by The Department of Veterans Affairs | Compositions and methods for treating tendon and bone injuries |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4466919A (en) | 1982-12-16 | 1984-08-21 | Monsanto Company | Peptide substrates for mammalian collagenase |
| US4507389A (en) | 1982-12-16 | 1985-03-26 | Monsanto Company | Determination of collagenase by reacting with peptide substrates |
| GB8927722D0 (en) | 1989-12-07 | 1990-02-07 | British Bio Technology | Proteins and nucleic acids |
| US5670617A (en) | 1989-12-21 | 1997-09-23 | Biogen Inc | Nucleic acid conjugates of tat-derived transport polypeptides |
| EP0730472B1 (en) * | 1993-11-16 | 2006-08-02 | Bracco International B.V. | Immobilized labelling method |
| US6592847B1 (en) | 1998-05-14 | 2003-07-15 | The General Hospital Corporation | Intramolecularly-quenched near infrared flourescent probes |
| US6083486A (en) | 1998-05-14 | 2000-07-04 | The General Hospital Corporation | Intramolecularly-quenched near infrared fluorescent probes |
| US6348185B1 (en) | 1998-06-20 | 2002-02-19 | Washington University School Of Medicine | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| US6436703B1 (en) | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| US20020009786A1 (en) | 2000-04-18 | 2002-01-24 | Tang Y. Tom | Novel nucleic acids and polypeptides |
| US7179784B2 (en) | 2001-07-10 | 2007-02-20 | Massachusetts Institute Of Technology | Surfactant peptide nanostructures, and uses thereof |
| US7371364B2 (en) | 2003-08-15 | 2008-05-13 | Board Of Regents, The University Of Texas System | Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy |
| US7431915B2 (en) | 2003-10-31 | 2008-10-07 | The Regents Of The University Of California | Peptides whose uptake by cells is controllable |
| US7985401B2 (en) * | 2003-10-31 | 2011-07-26 | The Regents Of The University Of California | Peptides whose uptake by cells is controllable |
| WO2011008992A2 (en) * | 2009-07-15 | 2011-01-20 | The Regents Of The University Of California | Peptides whose uptake in cells is controllable |
| US9695251B2 (en) | 2003-10-31 | 2017-07-04 | The Regents Of The University Of California | Activatable cell penetrating peptides with quenched fluorophores |
| CN107213469A (zh) | 2003-11-06 | 2017-09-29 | 西雅图基因公司 | 能够与配体偶联的单甲基缬氨酸化合物 |
| US8778880B2 (en) | 2004-02-02 | 2014-07-15 | Ambrx, Inc. | Human growth hormone modified at position 35 |
| US8148676B2 (en) * | 2005-06-07 | 2012-04-03 | Centre National De La Recherche Scientifique (Cnrs) | Use of ionic matrices for maldi mass spectrometry analysis of tissue sections |
| US9938333B2 (en) | 2008-02-08 | 2018-04-10 | Ambrx, Inc. | Modified leptin polypeptides and their uses |
| TW201004647A (en) | 2008-05-20 | 2010-02-01 | Sigma Tau Ind Farmaceuti | Novel dual targeting antitumoural conjugates |
| WO2010014236A2 (en) * | 2008-07-30 | 2010-02-04 | The University Of North Carolina At Chapel Hill | Acylhydrazone-based cleavable linkers |
| WO2010039496A2 (en) | 2008-09-23 | 2010-04-08 | The Regents Of The University Of California | Nanocarriers for drug delivery |
| US8278418B2 (en) | 2008-09-26 | 2012-10-02 | Ambrx, Inc. | Modified animal erythropoietin polypeptides and their uses |
| KR101095841B1 (ko) | 2009-02-19 | 2011-12-21 | 주식회사 나이벡 | 표적 선택적 세포／조직 투과기능 활성을 가지는 펩타이드 및 그 용도 |
| CA2755770A1 (en) | 2009-03-19 | 2010-09-23 | General Electric Company | Optical imaging agents |
| US8685372B2 (en) | 2009-04-15 | 2014-04-01 | The Regents Of The University Of California | Peptides and aptamers for targeting of neuron or nerves |
| CA2786470A1 (en) * | 2010-01-12 | 2011-07-21 | Ayelet David | Targeted delivery systems for diagnostic applications |
| JP5580625B2 (ja) | 2010-03-03 | 2014-08-27 | 住友化学株式会社 | メタンスルホン酸アルキルエステル溶液の製造方法 |
| US20120055055A1 (en) | 2010-09-02 | 2012-03-08 | Illumin8 Outdoor Media, LLC | Systems and Method for Outdoor Media Signage |
| TR201901259T4 (tr) | 2011-02-10 | 2019-02-21 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | Karaciğere özgü tanı için hidrofobik modifiye peptidler. |
| AU2012290318B2 (en) | 2011-07-29 | 2016-09-01 | Avelas Biosciences, Inc. | Selective delivery molecules and methods of use |
| US10029017B2 (en) | 2013-01-29 | 2018-07-24 | The Regents Of The University Of California | Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug |
| KR102363779B1 (ko) | 2013-01-30 | 2022-02-15 | 아벨라스 바이오사이언시즈 인코포레이티드 | 선택적 전달 분자 및 사용 방법 |
| EP2988786A4 (en) | 2013-04-22 | 2016-12-21 | Avelas Biosciences Inc | COMPOSITIONS FOR SELECTIVE DRUG ADMINISTRATION AND METHOD OF USE |
-
2012
- 2012-07-27 AU AU2012290318A patent/AU2012290318B2/en not_active Ceased
- 2012-07-27 KR KR1020147002685A patent/KR102004558B1/ko not_active Expired - Fee Related
- 2012-07-27 US US14/235,522 patent/US9278144B2/en active Active
- 2012-07-27 CN CN201280047936.9A patent/CN103874512B/zh not_active Expired - Fee Related
- 2012-07-27 EP EP18181420.3A patent/EP3473273A1/en not_active Withdrawn
- 2012-07-27 JP JP2014523099A patent/JP6124150B2/ja not_active Expired - Fee Related
- 2012-07-27 CA CA2841249A patent/CA2841249C/en active Active
- 2012-07-27 EP EP12820320.5A patent/EP2736533B1/en active Active
- 2012-07-27 WO PCT/US2012/048732 patent/WO2013019681A2/en not_active Ceased
- 2012-07-27 MX MX2014001138A patent/MX350082B/es active IP Right Grant
- 2012-07-27 ES ES12820320.5T patent/ES2683377T3/es active Active
- 2012-07-27 DK DK12820320.5T patent/DK2736533T3/en active
- 2012-07-27 EA EA201490385A patent/EA030795B1/ru not_active IP Right Cessation
-
2016
- 2016-01-26 US US15/006,832 patent/US9371367B1/en not_active Expired - Fee Related
- 2016-04-19 US US15/132,773 patent/US9504763B2/en not_active Expired - Fee Related
- 2016-10-17 US US15/295,482 patent/US9840537B2/en not_active Expired - Fee Related
-
2017
- 2017-11-07 US US15/806,246 patent/US10239919B2/en active Active
-
2018
- 2018-12-20 US US16/228,488 patent/US10570178B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014521661A5 (enExample) | ||
| Zhang et al. | Surface engineering of nanomaterials with phospholipid-polyethylene glycol-derived functional conjugates for molecular imaging and targeted therapy | |
| Ruan et al. | Mitochondrial temperature-responsive drug delivery reverses drug resistance in lung cancer | |
| Pasut et al. | Polymer–drug conjugation, recent achievements and general strategies | |
| CY1123978T1 (el) | Σταθερα και διαλυτα αντισωματα που αναστελλουν ton tnf | |
| Talanov et al. | Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging | |
| Don et al. | Temperature/pH/Enzyme triple-responsive cationic protein/PAA-b-PNIPAAm nanogels for controlled anticancer drug and photosensitizer delivery against multidrug resistant breast cancer cells | |
| Cheng et al. | Activable cell-penetrating peptide conjugated prodrug for tumor targeted drug delivery | |
| Sun et al. | RETRACTED ARTICLE: siRNA-loaded poly (histidine-arginine) 6-modified chitosan nanoparticle with enhanced cell-penetrating and endosomal escape capacities for suppressing breast tumor metastasis | |
| Li et al. | Self-assembled NIR-II fluorophores with ultralong blood circulation for cancer imaging and image-guided surgery | |
| Li et al. | Copolymer of poly (ethylene glycol) and poly (L-lysine) grafting polyethylenimine through a reducible disulfide linkage for siRNA delivery | |
| Brisson et al. | pH regulators in invadosomal functioning: proton delivery for matrix tasting | |
| Gao et al. | Bead-string-shaped DNA nanowires with intrinsic structural advantages and their potential for biomedical applications | |
| JP6247234B2 (ja) | グリコーゲンベースのカチオン性ポリマー | |
| US20210000934A1 (en) | Polymer adjuvant | |
| Jiang et al. | Degradable polyethylenimine-based gene carriers for cancer therapy | |
| JP2014534220A5 (enExample) | ||
| Kasala et al. | Utilizing adenovirus vectors for gene delivery in cancer | |
| Wang et al. | Dual‐targeting heparin‐based nanoparticles that re‐assemble in blood for glioma therapy through both anti‐proliferation and anti‐angiogenesis | |
| Oh et al. | Electrostatic charge conversion processes in engineered tumor-identifying polypeptides for targeted chemotherapy | |
| US20200078475A1 (en) | Polymeric systems and uses thereof in theranostic applications | |
| DE60106389D1 (de) | Vielseitige hydrophile farbstoffe | |
| CN104650194A (zh) | 一种肽类树状大分子药物及其制备方法和应用 | |
| CN111712524A (zh) | 对-二羟硼基苯丙氨酸衍生物和含有其的组合物、以及用于制备它们的试剂盒 | |
| JP2009542582A5 (enExample) |